← Back to Search

Amino Acid Supplement

Effects of Essential Amino Acid-enriched Whey and Carbohydrate Co-ingestion on Protein Kinetics

N/A
Waitlist Available
Led By Jess A Gwin, PhD
Research Sponsored by United States Army Research Institute of Environmental Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately 5.75 hours
Awards & highlights
No Placebo-Only Group

Summary

Previous work conducted by the Investigators demonstrates that an essential amino acid(EAA)-enriched whey protein combination format is an efficient EAA/protein format to support enhanced whole-body protein balance and sustain muscle protein synthesis compared to isonitrogenous amounts of whey alone or a mixed-macronutrient meal. However, additional work is needed to optimize the formulation to ensure the best possible muscle and whole-body anabolic responses are achieved. This includes addressing the potential value of adding non-EAA/protein components to support energy demands. Providing additional non-protein energy to an EAA-enriched whey protein formulation may reduce the proportion of exogenous amino acids directed towards energy production thereby preserving its use for muscle protein synthesis. However, whether suppressing exogenous amino acid oxidation by providing additional carbohydrate allows for a greater muscle protein synthetic stimulus during moderate energy deficit (- 30% total energy requirements) is unknown. Therefore, this study will test the effects of EAA-enriched whey protein plus carbohydrate versus EAA-enriched whey plus additional EAA using a randomized, cross-sectional longitudinal study design.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately 5.75 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately 5.75 hours for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Muscle Protein Synthesis
Whole-body Protein Balance
Whole-body Protein Breakdown
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups
Active Control
Group I: EAA+W & Carbohydrate: DEF first, then BALActive Control1 Intervention
Participants will consume an essential amino acid plus whey beverage with added Carbohydrate during energy deficit first, then again during energy balance.
Group II: EAA+W & Carbohydrate: Balance (BAL) first, then Deficit (DEF)Active Control1 Intervention
Participants will consume an essential amino acid plus whey (EAA+W) beverage with added Carbohydrate during energy balance (BAL) first, then again during energy deficit (DEF).
Group III: EAA+W & EAA: BAL first, then DEFActive Control1 Intervention
Participants will consume an essential amino acid (EAA) plus whey beverage with added EAA during energy balance first, then again during energy deficit.
Group IV: EAA+W & EAA: DEF first, then BALActive Control1 Intervention
Participants will consume an essential amino acid (EAA) plus whey beverage with added EAA during energy deficit first, then again during energy balance.

Find a Location

Who is running the clinical trial?

United States Army Research Institute of Environmental MedicineLead Sponsor
64 Previous Clinical Trials
3,617 Total Patients Enrolled
University of ArkansasOTHER
496 Previous Clinical Trials
150,374 Total Patients Enrolled
Eastern Michigan UniversityOTHER
4 Previous Clinical Trials
134 Total Patients Enrolled
Jess A Gwin, PhDPrincipal InvestigatorUS Army Research Institute of Environmental Medicine
1 Previous Clinical Trials
20 Total Patients Enrolled
~3 spots leftby Jan 2026